The center will be focused on new drug developments and manufacturing, using the competences of the Ningbo Institute of Drug Research as a core function. In addition, development of novel medical equipment will be of central interest. Total investments are planned at 4.85 billion yuan (650 million €).

China Bio news release, May 24, 2017